MS Briefs

Validity of Cognitive Assessment Battery for MS

Mult Scler Relat Disord; 2019 May; Golan, et al


 

The specific computerized assessment battery (CAB) evaluated is valid for cognitive screening of people with multiple sclerosis (MS) and may be more likely to detect prolonged response times and impaired executive function, according to a recent study. 81 people with MS (PwMS) and 15 healthy controls (HC) completed the CAB and a set of traditional neuropsychological tests recommended for MS on the same day. Principal component factor analysis was used to assess construct validity. For criterion validity, the gold standard definition of cognitive impairment was a score of ≥1.5SD below average on at least 1 cognitive domain, based upon traditional test normative data. Researchers found:

  • Traditional and computerized tests of memory, processing speed, visuospatial, and executive function converged by factor analysis.
  • Computerized tests detected cognitive impairment with 85% sensitivity and 70% specificity.
  • PwMS classified as impaired on only the computerized battery had significantly prolonged response times and a higher rate of unemployment compared with PwMS classified as unimpaired on both batteries.
  • Poor executive function was more likely to be revealed by the CAB.

Golan D, Wilken J, Doniger GM, et al. Validity of a multi-domain computerized cognitive assessment battery for patients with multiple sclerosis. Mult Scler Relat Disord . 2019(30):154–162. doi:10.1016/j.msard.2019.01.051.

Recommended Reading

DMTs, stem cell transplants both reduce disease progression in MS
ICYMI Multiple Sclerosis
Examining Pseudobulbar Affect in Multiple Sclerosis
ICYMI Multiple Sclerosis
Body Composition, Disability in People with MS
ICYMI Multiple Sclerosis
Core Temperature Not Elevated at Rest in RRMS
ICYMI Multiple Sclerosis
Joseph R. Berger, MD
ICYMI Multiple Sclerosis
Interview with Joseph R. Berger, MD, on the Financial Contribution of the MS Specialist
ICYMI Multiple Sclerosis
Global Burden of Multiple Sclerosis, 1990-2018
ICYMI Multiple Sclerosis
Trait Conscientiousness and SDMT Decline in MS
ICYMI Multiple Sclerosis
Depression, Fatigue, and Cognitive Functioning in MS
ICYMI Multiple Sclerosis
2010 MS Prevalence in the US Highest Ever to Date
ICYMI Multiple Sclerosis